| Not Yet Recruiting | Study on the Pharmacokinetic Characteristics of Liposomal Amphotericin B in Patients With Invasive Fungal Infe NCT07532850 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Active Not Recruiting | Human Bioequivalence Study of Liposomal Amphotericin B for Injection NCT06983665 | Sichuan Huiyu Pharmaceutical Co., Ltd | N/A |
| Completed | Human Bioequivalence Study of Amphotericin B Liposome for Injection NCT06977490 | Sichuan Huiyu Pharmaceutical Co., Ltd | N/A |
| Not Yet Recruiting | Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygena NCT06754436 | Beijing Anzhen Hospital | Phase 4 |
| Recruiting | Breath Analysis for the Detection of Invasive Fungal Infections NCT06537726 | University of Zurich | — |
| Active Not Recruiting | Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections NCT07120581 | Assaf-Harofeh Medical Center | — |
| Not Yet Recruiting | Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province ( NCT06346951 | Sichuan Provincial People's Hospital | — |
| Not Yet Recruiting | PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitali NCT06220370 | Kirby Institute | — |
| Enrolling By Invitation | L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis NCT06640296 | Istituto Giannina Gaslini | — |
| Recruiting | Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions NCT06105411 | Peter MacCallum Cancer Centre, Australia | — |
| Unknown | Using of Biomarkers and Blood Culture in Early Detection of Systemic Infections NCT05737537 | Assiut University | N/A |
| Recruiting | Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients NCT06498310 | University Hospital, Strasbourg, France | — |
| Terminated | Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age NCT05534529 | Mundipharma Research Limited | Phase 1 |
| Recruiting | Usefulness of PET-CT for Invasive Fungal Infection NCT05688592 | Puerta de Hierro University Hospital | — |
| Completed | Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients NCT05611892 | Johns Hopkins University | — |
| Completed | Evaluation of a Clinical Decision Support System for Fungal Infections NCT05656157 | Hospices Civils de Lyon | — |
| Completed | Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection NCT06413056 | Ain Shams University | Phase 4 |
| Unknown | Pharmacokinetics of Fluconazole in Children (2-18 Years) NCT05130723 | Radboud University Medical Center | — |
| Recruiting | Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative NCT05750706 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Fungal Surveillance in Bangladesh NCT06103331 | International Centre for Diarrhoeal Disease Research, Bangladesh | — |
| Completed | Invasive Fungal Infections in Patients Following Stem Cell Transplant NCT04619147 | Peter MacCallum Cancer Centre, Australia | — |
| Unknown | A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005. NCT04921254 | Biosergen AS | Phase 1 |
| Completed | A Bioequivalence Study of APX001 High-load and Low-load Tablets NCT05491733 | Basilea Pharmaceutica | Phase 1 |
| Completed | Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit NCT04777058 | Radboud University Medical Center | — |
| Completed | Pharmacokinetics and Safety of AmBisome and DKF-5122 NCT05749380 | Dongkook Pharmaceutical Co., Ltd. | Phase 1 |
| Terminated | Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Ra NCT04240886 | Basilea Pharmaceutica | Phase 2 |
| Unknown | Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy NCT04238884 | Instituto de Investigación Hospital Universitario La Paz | Phase 4 |
| Completed | Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Admin NCT04122560 | Radboud University Medical Center | Phase 4 |
| Completed | Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients NCT04157465 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Completed | Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies NCT04024995 | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | — |
| Completed | Absorption, Metabolism and Excretion of 14C-olorofim in Man NCT04039880 | F2G Biotech GmbH | Phase 1 |
| Completed | Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole NCT03572049 | University of Alabama at Birmingham | Phase 2 / Phase 3 |
| Completed | Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options NCT03583164 | F2G Biotech GmbH | Phase 2 |
| Completed | Granulomatous Pneumocystis Pneumonia NCT03731156 | University Hospital, Montpellier | — |
| Completed | Population Pharmacokinetics and Dose Optimization of Caspofungin in Adolescents NCT05881109 | Shandong University | — |
| Completed | Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Ocea NCT03174457 | Astellas Pharma Singapore Pte. Ltd. | — |
| Completed | Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients NCT03262584 | Karius, Inc. | — |
| Completed | ImPACt on Invasive Fungal Infections by Immune Checkpoint Inhibition NCT04533087 | University of Cologne | — |
| Unknown | Cost-Effectiveness of Amphotericin B NCT02527928 | Hospital Universitario Evangelico de Curitiba | — |
| Completed | A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fun NCT02678598 | Astellas Pharma China, Inc. | — |
| Completed | Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients NCT02851680 | Centre Hospitalier Universitaire Dijon | N/A |
| Completed | A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and He NCT01519648 | National Hematological Society, Russia | — |
| Terminated | Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients NCT00982540 | Universidade Federal do Rio de Janeiro | N/A |
| Completed | Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients NCT00745992 | National Taiwan University Hospital | — |
| Completed | Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) NCT00750737 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi NCT00634049 | Astellas Pharma Inc | Phase 3 |
| Completed | Anidulafungin PK in Infants and Toddlers NCT00734500 | Michael Cohen-Wolkowiez | Phase 1 |
| Completed | Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive F NCT01137292 | Pfizer | — |
| Completed | A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal NCT00288197 | Pfizer | Phase 4 |
| Terminated | Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU NCT00048750 | Astellas Pharma Inc | Phase 3 |
| Available | Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections NCT06433128 | Basilea Pharmaceutica | — |